Tristan Gallenne

801 total citations
14 papers, 633 citations indexed

About

Tristan Gallenne is a scholar working on Molecular Biology, Oncology and Radiology, Nuclear Medicine and Imaging. According to data from OpenAlex, Tristan Gallenne has authored 14 papers receiving a total of 633 indexed citations (citations by other indexed papers that have themselves been cited), including 11 papers in Molecular Biology, 7 papers in Oncology and 7 papers in Radiology, Nuclear Medicine and Imaging. Recurrent topics in Tristan Gallenne's work include Monoclonal and Polyclonal Antibodies Research (7 papers), HER2/EGFR in Cancer Research (6 papers) and Cell death mechanisms and regulation (5 papers). Tristan Gallenne is often cited by papers focused on Monoclonal and Polyclonal Antibodies Research (7 papers), HER2/EGFR in Cancer Research (6 papers) and Cell death mechanisms and regulation (5 papers). Tristan Gallenne collaborates with scholars based in France, Netherlands and United States. Tristan Gallenne's co-authors include Fabien Gautier, Philippe Juin, François M. Vallette, Pierre‐François Cartron, Florence Manero, Patricia Vusio, Khaled Méflah, Gwenola Bougras, Olivier Geneste and Nicolas Cauquil and has published in prestigious journals such as Proceedings of the National Academy of Sciences, The Journal of Experimental Medicine and Journal of Clinical Oncology.

In The Last Decade

Tristan Gallenne

14 papers receiving 626 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Tristan Gallenne France 8 458 206 89 89 74 14 633
Xiaochun Yu United States 11 495 1.1× 424 2.1× 85 1.0× 114 1.3× 48 0.6× 20 725
Rajesh Patel United States 9 302 0.7× 176 0.9× 27 0.3× 55 0.6× 135 1.8× 20 604
Luciana M. Laguinge United States 7 309 0.7× 122 0.6× 39 0.4× 74 0.8× 37 0.5× 9 471
Luca Bagnasco Italy 13 311 0.7× 89 0.4× 33 0.4× 54 0.6× 31 0.4× 17 420
Philippe Depeille United States 13 437 1.0× 162 0.8× 17 0.2× 108 1.2× 73 1.0× 15 616
Neil P. Jones United Kingdom 12 431 0.9× 98 0.5× 26 0.3× 95 1.1× 197 2.7× 12 628
Petra Ohneseit Germany 10 258 0.6× 126 0.6× 41 0.5× 24 0.3× 110 1.5× 14 460
Youngrok Park United States 5 228 0.5× 214 1.0× 12 0.1× 147 1.7× 139 1.9× 8 486
Hong‐Jun Liao United States 8 308 0.7× 162 0.8× 87 1.0× 50 0.6× 38 0.5× 11 485
Midan Ai United States 9 178 0.4× 322 1.6× 40 0.4× 326 3.7× 181 2.4× 13 627

Countries citing papers authored by Tristan Gallenne

Since Specialization
Citations

This map shows the geographic impact of Tristan Gallenne's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Tristan Gallenne with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Tristan Gallenne more than expected).

Fields of papers citing papers by Tristan Gallenne

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Tristan Gallenne. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Tristan Gallenne. The network helps show where Tristan Gallenne may publish in the future.

Co-authorship network of co-authors of Tristan Gallenne

This figure shows the co-authorship network connecting the top 25 collaborators of Tristan Gallenne. A scholar is included among the top collaborators of Tristan Gallenne based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Tristan Gallenne. Tristan Gallenne is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

14 of 14 papers shown
1.
Geuijen, Cecile, David Maussang, Tristan Gallenne, et al.. (2021). Unbiased Combinatorial Screening Identifies a Bispecific IgG1 that Potently Inhibits HER3 Signaling via HER2-Guided Ligand Blockade. Cancer Cell. 39(8). 1163–1164. 2 indexed citations
2.
Deshière, Alexandre, Martijn van Rosmalen, Christian Wohn, et al.. (2021). Abstract 952: The bispecific antibody MCLA-129 impairs NSCLC tumor growth by targeting EGFR and c-MET, inhibiting ligand-induced signaling and promoting ADCC and ADCP. Cancer Research. 81(13_Supplement). 952–952. 5 indexed citations
3.
Geuijen, Cecile, Tristan Gallenne, Linda Hendriks, et al.. (2021). Abstract 957: Zenocutuzumab: An antibody that can overcome HER3 mediated HRG signalling in tumor cells by docking on HER2. Cancer Research. 81(13_Supplement). 957–957. 2 indexed citations
4.
Geuijen, Cecile, Mario Di Matteo, Tristan Gallenne, et al.. (2019). Abstract LB-C07: Preclinical evaluation of MCLA-129: A bispecific antibody targeting c-MET and EGFR. Molecular Cancer Therapeutics. 18(12_Supplement). LB–C07. 2 indexed citations
5.
Geuijen, Cecile, David Maussang, Tristan Gallenne, et al.. (2018). Unbiased Combinatorial Screening Identifies a Bispecific IgG1 that Potently Inhibits HER3 Signaling via HER2-Guided Ligand Blockade. Cancer Cell. 33(5). 922–936.e10. 84 indexed citations
6.
Gallenne, Tristan, Kenneth N. Ross, Nils L. Visser, et al.. (2017). Systematic functional perturbations uncover a prognostic genetic network driving human breast cancer. Oncotarget. 8(13). 20572–20587. 30 indexed citations
7.
Hendriks, Linda, Tristan Gallenne, Robert P. Doornbos, et al.. (2017). Abstract 33: The binding mode of the bispecific anti-HER2xHER3 antibody MCLA-128 is responsible for its potent inhibition of HRG-driven tumorigenesis. Cancer Research. 77(13_Supplement). 33–33. 2 indexed citations
8.
Geuijen, Cecile, Therèse Visser, Willem Bartelink, et al.. (2014). Preclinical activity of MCLA-128, an ADCC enhanced bispecific IgG1 antibody targeting the HER2:HER3 heterodimer.. Journal of Clinical Oncology. 32(15_suppl). 560–560. 12 indexed citations
9.
Desmet, Christophe, Tristan Gallenne, Alexandre Prieur, et al.. (2013). Identification of a pharmacologically tractable Fra-1/ADORA2B axis promoting breast cancer metastasis. Proceedings of the National Academy of Sciences. 110(13). 5139–5144. 136 indexed citations
10.
Gauthier, France, Pierre‐François Cartron, Tristan Gallenne, et al.. (2011). Bax activation by engagement with, then release from, the BH3 binding site of Bcl-xL.. HAL (Le Centre pour la Communication Scientifique Directe). 2 indexed citations
11.
Gautier, Fabien, Yannis Guillemin, Pierre‐François Cartron, et al.. (2010). Bax Activation by Engagement with, Then Release from, the BH3 Binding Site of Bcl-x L. Molecular and Cellular Biology. 31(4). 832–844. 30 indexed citations
12.
Gallenne, Tristan, Fabien Gautier, Lisa Oliver, et al.. (2009). Bax activation by the BH3-only protein Puma promotes cell dependence on antiapoptotic Bcl-2 family members. The Journal of Experimental Medicine. 206(5). i8–i8. 8 indexed citations
13.
Manero, Florence, Fabien Gautier, Tristan Gallenne, et al.. (2006). The Small Organic Compound HA14-1 Prevents Bcl-2 Interaction with Bax to Sensitize Malignant Glioma Cells to Induction of Cell Death. Cancer Research. 66(5). 2757–2764. 113 indexed citations
14.
Cartron, Pierre‐François, Tristan Gallenne, Gwenola Bougras, et al.. (2004). The First α Helix of Bax Plays a Necessary Role in Its Ligand-Induced Activation by the BH3-Only Proteins Bid and PUMA. Molecular Cell. 16(5). 807–818. 205 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Xiaochun Yu Breakdown of academic impact, for papers by Rajesh Patel Breakdown of academic impact, for papers by Luciana M. Laguinge Breakdown of academic impact, for papers by Luca Bagnasco Breakdown of academic impact, for papers by Philippe Depeille Breakdown of academic impact, for papers by Neil P. Jones Breakdown of academic impact, for papers by Petra Ohneseit Breakdown of academic impact, for papers by Youngrok Park Breakdown of academic impact, for papers by Hong‐Jun Liao Breakdown of academic impact, for papers by Midan Ai
Rankless by CCL
2026